Hep C Virus - Schering-Plough and PTC ink hepatitis C deal

Schering-Plough and PTC ink hepatitis C deal
Pharmaceutical Business Review - Mar 21, 2006... PTC's small molecules are designed to inhibit the hepatitis C virus (HCV) internal ribosome entry site (IRES) mediated production of viral proteins. ...

Chronic hepatitis C treatment may be aided by thalidomide
Therapeutics Daily (subscription) (press release), PA - Mar 27, 2006... authors wrote, "We investigated the efficacy and safety of a 24-wk course of thalidomide at a dosage of 200 mg/day in eight patients with HCV chronic hepatitis ...

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - Mar 15, 2006... puts Albuferon in a strong position to potentially replace pegylated interferon, the drug's success might be delayed by the approval of specific HCV inhibitors ...

BHIVA: HIV/HCV coinfected may have worse survival as they spend ...
Aidsmap, UK - Apr 4, 2006HIV-positive individuals who are coinfected with the hepatitis C virus appear to have slightly worse survival than patients who are only infected with HIV ...